^
    BIOMARKER:

    PD-L1 negative

    i
    Other names: PD-L1, CD274, HPD-L1, PD-L1, B7H1, PDL1, Programmed death ligand 1, B7-H1, B7-H, PDCD1L1, PDCD1LG1, PDCD1 Ligand 1, B7 homolog 1, CD274 Antigen, Programmed cell death 1 ligand 1, CD274 molecule




    Show legend

    Include preclinical:
    Squamous Cell Carcinoma of Head and Neck
    Non Small Cell Lung Cancer
    Melanoma
    Triple Negative Breast Cancer
    Cervical Cancer
    Small Cell Lung Cancer
    Head and Neck Cancer
    Urothelial Cancer
    Vulvar Cancer
    Lung Non-Squamous Non-Small Cell Cancer
    Merkel Cell Carcinoma
    Colon Cancer
    pembrolizumab
    cetuximab
    5-fluorouracil
    methotrexate
    TPeX
    Immunotherapy
    ABBV-181
    pembrolizumab + ipilimumab
    nivolumab + IPI-549
    anlotinib + camrelizumab
    AGEN2034
    pembrolizumab + tirvalimogene teraplasmid
    nivolumab + IO102-IO103
    bevacizumab
    XTX101
    bevacizumab + atezolizumab
    avelumab + VX15
    pembrolizumab + SNS-301
    avelumab
    nivolumab + ipilimumab
    SAR445710
    nivolumab